SREBP

SREBP产品

  • 所有产品(4)
  • SREBP抑制剂 (4)
目录号 产品名 产品描述 文献引用 实验数据
S8284 Fatostatin HBr Fatostatin HBr是固醇调节元件结合蛋白(SREBP)的抑制剂。它损害SREBP-1和SREBP-2的激活。
Cell Rep, 2023, 42(8):112963
Respir Res, 2023, 24(1):8
Ann Transl Med, 2022, 10(18):958
S9785 Fatostatin Fatostatin (125B11) 是一种diarylthiazole的衍生物,是 Sterol regulatory element binding proteins (SREBPs) 活化的特异性抑制剂。Fatostatin 可结合SCAP (SREBP cleavage-activating protein),并抑制SREBP的ER-Golgi易位。Fatostatin 可抑制癌细胞生长并增强癌细胞的凋亡。
Oncogene, 2024, 43(4):281-293
Biochem Pharmacol, 2024, 224:116207
bioRxiv, 2024, 10.1101/2024.01.16.575899
S9067 Pseudoprotodioscin Pseudoprotodioscin is a steroidal saponin from plants and exhibits anti-inflammatory and anticancer activities. Pseudoprotodioscin inhibits SREBP1/2 and microRNA 33a/b levels and reduces the gene expression regarding the synthesis of cholesterol and triglycerides.
E0209 Cinobufotalin Cinobufotalin,可从巨蟾的皮肤分泌物中提取,是一种新型的 SREBP1 抑制剂,通过靶向脂肪生成来抑制肝细胞癌的增殖。
S8284 Fatostatin HBr Fatostatin HBr是固醇调节元件结合蛋白(SREBP)的抑制剂。它损害SREBP-1和SREBP-2的激活。
Cell Rep, 2023, 42(8):112963
Respir Res, 2023, 24(1):8
Ann Transl Med, 2022, 10(18):958
S9785 Fatostatin Fatostatin (125B11) 是一种diarylthiazole的衍生物,是 Sterol regulatory element binding proteins (SREBPs) 活化的特异性抑制剂。Fatostatin 可结合SCAP (SREBP cleavage-activating protein),并抑制SREBP的ER-Golgi易位。Fatostatin 可抑制癌细胞生长并增强癌细胞的凋亡。
Oncogene, 2024, 43(4):281-293
Biochem Pharmacol, 2024, 224:116207
bioRxiv, 2024, 10.1101/2024.01.16.575899
S9067 Pseudoprotodioscin Pseudoprotodioscin is a steroidal saponin from plants and exhibits anti-inflammatory and anticancer activities. Pseudoprotodioscin inhibits SREBP1/2 and microRNA 33a/b levels and reduces the gene expression regarding the synthesis of cholesterol and triglycerides.
E0209 Cinobufotalin Cinobufotalin,可从巨蟾的皮肤分泌物中提取,是一种新型的 SREBP1 抑制剂,通过靶向脂肪生成来抑制肝细胞癌的增殖。

SREBP抑制剂选择性比较

Tags: SREBP inhibitor|SREBP agonist|SREBP activator|SREBP inducer|SREBP antagonist|SREBP signaling pathway|SREBP assay kit
在线咨询
联系我们